Afuco™ Anti-Human TREM1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TREM1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that are capable of specifically binding TREM-1 and preventing the activation of TREM-1, a protein expressed on monocytes, macrophages and neutrophils. Such antibodies find utility in the treatment of individuals with an inflammatory disease, such as rheumatoid arthritis and inflammatory bowel disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-620CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TREM1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |